Korea Joongang Daily

Home > >

Sanofi pulls out of Hanmi diabetes drug trials, ends contract

Paris-based Sanofi has decided to drop ongoing Phase 3 clinical trials and marketing rights of Hanmi Pharmaceutical’s efpeglenatide, a diabetes drug.

2020-09-09

Chairman of Hanmi Pharmaceutical Lim Sung-ki dead at 80

Lim Sung-ki, founder and chairman of Hanmi Pharmaceutical, one of Korea’s top drugmakers, passed away on the early morning of Aug. 2 at the age of 80 from chronic illness.

2020-08-02

Sanofi seeking to walk away from huge deal with Hanmi

Paris-based Sanofi is seeking an exit from a deal with Hanmi Pharmaceutical involving global marketing rights to efpeglenatide, a diabetes drug. Shares of Kospi-listed Hanmi fell almost 10 percent on the news.

2020-05-14

Brokerages slash target prices for shares in Hanmi

Shares of Hanmi Pharmaceutical nosedived Tuesday to a low for the year after the company came under investigation for alleged insider trading and brokerages slashed target prices for the stock. The country’s top drug maker is suspected of delaying

2016-10-04

What’s Popular Now